BIG FUNDING FOR MODERNA COVID VACCINE
Another $472 Million in Funds from US Government Source: Stock image of COVID vaccine Potentially Quick Development and Delivery Cambridge, MA based Moderna just announced it has received an additional $472 million in funding from the US government's Biomedical Advanced Research and Development Authority (BARDA). That brings the total from BARDA to support the development of Moderna's novel COVID vaccine to $955 million. Audible Gift Memberships mRNA Moderna is the first pharma company in the US to begin human trials on a COVID vaccine. Tomorrow, July 27th, a Phase 3 study involving 30,000 participants will get underway with Moderna collaborating with the National Institute of Allergy and Infectious Diseases. Moderna's vaccine candidate uses synthetic messenger RNA (mRNA) to help the body immunize against the virus. Potential Quick Delivery Moderna says it can deliver 500,000 doses of the vaccine per year and possibly 1 billion doses per ye...